Biopharma companies make big bets and investments in every single drug candidate that enters the drug development process. Yet, making difficult strategic decisions on which trials to pursue, how to design trials (e.g. head-to-head; which drug candidate; non-inferiority or superiority; which primary and secondary endpoints; which bio-markers; which types of patients), and how to increase the overall probability of success, hasn’t changed in many years. Recently, companies are moving toward investing more heavily in clinical and real world data and bringing in AI solutions in order to have new tools to help make these important decisions.
In this on demand webinar, the GNS team will share how they have leveraged its causal AI technology to help biopharma partners more efficiently identify patients for trial enrollment and utilized diverse data assets to improve clinical trial efficiency.
In this 30 minute webinar, we will cover:

